Cox Capital Mgt LLC Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cox Capital Mgt LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 46.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,559 shares of the healthcare conglomerate’s stock after selling 3,983 shares during the period. UnitedHealth Group comprises about 1.7% of Cox Capital Mgt LLC’s portfolio, making the stock its 24th biggest position. Cox Capital Mgt LLC’s holdings in UnitedHealth Group were worth $2,388,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.0%

Shares of UNH stock opened at $301.08 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $430.87 and its two-hundred day moving average is $492.75. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a market capitalization of $273.12 billion, a P/E ratio of 19.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the business posted $6.91 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Truist Financial reiterated a “buy” rating and set a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Morgan Stanley decreased their target price on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Finally, HSBC reissued a “reduce” rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $441.87.

Insider Activity

In related news, Director Kristen Gil acquired 3,700 shares of the firm’s stock in a transaction that occurred on Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.